Help us: Donate
Follow us on:
×

Tag: atherosclerosis

July 02, 2020
Researchers have found out how LDL cholesterol is able to enter our cells with the help of two proteins that form a doorway into the cell. The findings have ramifications for treating heart disease, which is currently the world's greatest killer. Revealing how LDL gets into our cells We have all likely heard about good...
June 26, 2020
Cyclodextrins have been of particular interest in the context of treating atherosclerosis, so today we want to highlight some interesting research that uses a novel delivery method to combat this disease. Nanoparticles improve drug delivery Cyclodextrins describe a group of cyclic oligosaccharides, which have a varied range of uses in the food, pharmaceutical, drug delivery,...
June 25, 2020
A new study has seen researchers alter the balance of harmful bacteria in the gut microbiome to reduce cholesterol and reverse atherosclerosis in mice fed a high-fat Western diet. What is the gut microbiome? The gut microbiome describes the varied community of bacteria, archaea, eukarya, and viruses that inhabit our gut. The four bacterial phyla...
January 30, 2020
Researchers from Stanford University and Michigan State University have teamed up to create a nanoparticle that can eat away at the arterial plaques that lead to strokes and heart attacks in a mouse model of atherosclerosis. The team has created a nanoparticle that acts like a Trojan horse, targeting atherosclerotic plaque to reduce its amount...
January 09, 2020
There are lots of exciting companies working in the aging field, and it's a great time to tell you about three of the more interesting ones. Most of these companies are a while away from human trials yet, but their innovations could possibly be truly game changing. Underdog Pharma Underdog Pharmaceuticals is a spin-off company...
December 04, 2019
For the December edition of the Journal Club hosted by Dr. Oliver Medvedik, we are joined by Dr. Matthew O' Connor (Oki) formerly of SENS Research Foundation and now the head researcher at Underdog Pharma, a spun-off biotech company that is developing research conducted at SENS into a hopefully viable solution for heart disease. Dr....